Cargando…

Physical Exercise as Disease-Modifying Alternative against Alzheimer’s Disease: A Gut–Muscle–Brain Partnership

Alzheimer’s disease (AD) is a common cause of dementia characterized by neurodegenerative dysregulations, cognitive impairments, and neuropsychiatric symptoms. Physical exercise (PE) has emerged as a powerful tool for reducing chronic inflammation, improving overall health, and preventing cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cutuli, Debora, Decandia, Davide, Giacovazzo, Giacomo, Coccurello, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572207/ https://www.ncbi.nlm.nih.gov/pubmed/37834132 http://dx.doi.org/10.3390/ijms241914686

Ejemplares similares

Alzheimer’s disease and depression in the elderly: A trajectory linking gut microbiota and serotonin signaling
por: Cutuli, Debora, et al.
Publicado: (2022)

The neuronal Shc adaptor in Alzheimer’s Disease
por: Triaca, Viviana, et al.
Publicado: (2018)

Editorial: The affective side of Alzheimer's disease (AD): neuropsychiatric symptoms as early sentinel of cognitive decline and pathogenetic factors in disease progression
por: Cutuli, Debora, et al.
Publicado: (2023)

Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer’s Disease Animal Models of Lipopolysaccharide-Induced Inflammation
por: Decandia, Davide, et al.
Publicado: (2023)

Oleoylethanolamide: A Novel Potential Pharmacological Alternative to Cannabinoid Antagonists for the Control of Appetite
por: Romano, Adele, et al.
Publicado: (2014)

The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
por: Coccurello, Roberto, et al.
Publicado: (2022)

Lack of cyclin D3 induces skeletal muscle fiber-type shifting, increased endurance performance and hypermetabolism
por: Giannattasio, Silvia, et al.
Publicado: (2018)

Stimulation of P2X7 Enhances Whole Body Energy Metabolism in Mice
por: Giacovazzo, Giacomo, et al.
Publicado: (2019)

Environmental Enrichment Protects against Neurotoxic Effects of Lipopolysaccharide: A Comprehensive Overview
por: Landolfo, Eugenia, et al.
Publicado: (2023)

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
por: Nobili, Annalisa, et al.
Publicado: (2017)

Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
por: Latina, Valentina, et al.
Publicado: (2021)

n-3 PUFA Improve Emotion and Cognition during Menopause: A Systematic Review
por: Decandia, Davide, et al.
Publicado: (2022)

Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?
por: Giacovazzo, Giacomo, et al.
Publicado: (2019)

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
por: Corsetti, Veronica, et al.
Publicado: (2020)

Sex Differences in Neuropathy: The Paradigmatic Case of MetFormin
por: De Angelis, Federica, et al.
Publicado: (2022)

Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
por: Latina, Valentina, et al.
Publicado: (2021)

Transcriptome Analysis in a Mouse Model of Premature Aging of Dentate Gyrus: Rescue of Alpha-Synuclein Deficit by Virus-Driven Expression or by Running Restores the Defective Neurogenesis
por: Micheli, Laura, et al.
Publicado: (2021)

Genetic Heterogeneity of Alzheimer’s Disease: Embracing Research Partnerships
por: Nacmias, Benedetta, et al.
Publicado: (2018)

Gut Microbiota and Bone Diseases: A Growing Partnership
por: Chen, Yu, et al.
Publicado: (2022)

Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice
por: Coccurello, Roberto, et al.
Publicado: (2018)

Sex-specific adipose tissue’s dynamic role in metabolic and inflammatory response following peripheral nerve injury
por: Vacca, Valentina, et al.
Publicado: (2023)

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1(G93A) Mice Predates Disease Onset and Is A Promising Therapeutic Target
por: Scaricamazza, Silvia, et al.
Publicado: (2020)

Editorial: How does exercise modify the course of Alzheimer's disease?
por: Arciero, Paul J., et al.
Publicado: (2023)

Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?
por: Cerovic, Milica, et al.
Publicado: (2019)

Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease
por: Marcos Pasero, Helena, et al.
Publicado: (2022)

Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases
por: Marrone, Maria Cristina, et al.
Publicado: (2019)

Alternative Splicing in Alzheimer’s Disease
por: Love, Julia E., et al.
Publicado: (2015)

Alzheimer's disease: An alternative approach
por: Chandra, Sadanandavalli Retnaswami
Publicado: (2017)

Disease-modifying drugs in Alzheimer’s disease
por: Ghezzi, Laura, et al.
Publicado: (2013)

Disease-modifying treatments in Alzheimer’s disease
por: Edwards, Marc, et al.
Publicado: (2023)

Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease
por: Frederiksen, Kristian S., et al.
Publicado: (2019)

Exercise modifies the disease-relevant gut microbial shifts in post-traumatic osteoarthritis rats
por: Hao, Xiaoxia, et al.
Publicado: (2022)

Public–private partnerships improve health outcomes in individuals with early stage Alzheimer’s disease
por: Galvin, James E, et al.
Publicado: (2014)

Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
por: Chen, Daoyuan, et al.
Publicado: (2023)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

Antibiotics, gut microbiota, and Alzheimer’s disease
por: Angelucci, Francesco, et al.
Publicado: (2019)

Gut Microbiota: Implications in Alzheimer’s Disease
por: He, Yixi, et al.
Publicado: (2020)

Nutrition, Gut Microbiota, and Alzheimer's Disease
por: Romanenko, Mariana, et al.
Publicado: (2021)

Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022)

Innovative Partnerships for Drug Discovery against Neglected Diseases
por: Jakobsen, Palle H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_re0pd3gm96tff4jql7o7ma4eii